Results 1 to 10 of about 584,093 (236)
Effective Treatment With Oral Sulfonylureas in Patients With Diabetes Due to Sulfonylurea Receptor 1 (SUR1) Mutations [PDF]
OBJECTIVE—Neonatal diabetes can result from mutations in the Kir6.2 or sulfonylurea receptor 1 (SUR1) subunits of the ATP-sensitive K+ channel. Transfer from insulin to oral sulfonylureas in patients with neonatal diabetes due to Kir6.2 mutations is well described, but less is known about changing therapy in patients with SUR1 mutations.
Andrew Tym Hattersley +2 more
exaly +6 more sources
Frances Ashcroft +2 more
exaly +3 more sources
Effects of Sulfonylureas on Peroxisome Proliferator-Activated Receptor γ Activity and on Glucose Uptake by Thiazolidinediones [PDF]
BackgroundSulfonylurea primarily stimulates insulin secretion by binding to its receptor on the pancreatic β-cells. Recent studies have suggested that sulfonylureas induce insulin sensitivity through peroxisome proliferator-activated receptor γ (PPARγ ...
Kyeong Won Lee +5 more
doaj +1 more source
Background. The purpose was to investigate the effect of therapy with glucagon-like peptide-1 receptor agonists (GLP-1ra) on the serum concentration of trimethylamine-N-oxide (TMAO), an intestinal microbiome metabolite, in patients with type 2 diabetes ...
K.O. Shyshkan-Shyshova +4 more
doaj +1 more source
Type 2 diabetes therapy at the time of diagnosis. Glimepiride: property, efficiency, safety
В клинической практике имеется эффективный сахароснижающий препарат Амарил, обеспечивающий хороший контроль гликемии при однократном приеме, способствующий снижению массы тела, не имеющий побочных действий, обладающий экстрапанкреатическим ...
Olga Mikhailovna Smirnova
doaj +1 more source
Transmembrane Topology of the Sulfonylurea Receptor SUR1 [PDF]
Sulfonylurea receptors (SURx) are multi-spanning transmembrane proteins of the ATP-binding cassette (ABC) family, which associate with Kir6.x to form ATP-sensitive potassium channels. Two models, with 13-17 transmembrane segments, have been proposed for SURx topologies.
L R, Conti +3 more
openaire +2 more sources
An endogenous ligand for the central sulfonylurea receptor [PDF]
An endogenous ligand for the rat central sulfonylurea receptor has been evidenced in the rat central nervous system. The characteristics of this ligand (extractibility, non‐dialysability, chromatographic behaviour on different media, sensitivity to proteases) indicate that it is a neutral to slightly basic peptide.
Virsolvy-Vergine, A. +5 more
openaire +2 more sources
Optimization of therapy of type 2 diabetes mellitus with the oral hypoglycemic agent glimepiride
Type 2 diabetes is believed to develop as a result of lowered insulin secretion and insulin resistance leading to hyperglycemia. Sulfonylureas stimulateinsulin secretion and thereby decrease blood glucose level which accounts for their wide application ...
Tatiana Ivanovna Romantsova +1 more
doaj +1 more source
The mechanism of the hypoglycaemic action of sulfonylurea agents remains controversial, in spite of the fact that they have been widely used in the clinical management of patients with NIDDM. in this study, we used insulin clearance and euglycaemic clamp
Ahmet Gökhan Özgen +7 more
doaj +2 more sources
The unusual stoichiometry of ADP activation of the KATP channel
KATP channels, oligomers of 4 pore-forming Kir6.2 proteins and 4 sulfonylurea receptors (SUR), sense metabolism by monitoring both cytosolic ATP, which closes the channel by interacting with Kir6.2, and ADP, which opens it via SUR.
Eric eHosy, Michel eVivaudou
doaj +1 more source

